Codify Roe v. Wade Nationally
Establish a federal right to abortion care through viability, ensuring access regardless of state politics.

Cap Medicare Drug Prices at Global Benchmark
Prevent Medicare from paying more than the lowest price paid by European Union countries.

Ban Direct-to-Consumer Prescription Drug Ads
End pharmaceutical television advertising and bar drug companies from giving gifts to doctors.

Over-the-Counter Access Expansion
Require FDA to fast-track safe OTC switches for routine drugs (e.g., birth control pills, cholesterol meds).

Break Up Hospital Monopolies That Drive Up Prices
Empower the Federal Trade Commission and Department of Justice to block future hospital mergers, unwind anti-competitive consolidations, and investigate price gouging by dominant regional hospital systems.

Hospital Price Transparency Enforcement

Require hospitals to publish real prices online and fine them meaningfully if they don’t comply.

Overhaul State Based Insurance Market Fragmentation

Allow consumers to buy ACA plans across state lines through a federal exchange option to boost competition and reduce regional monopolies.

Ban Harmful Food Additives Already Outlawed Abroad
Prohibit five food additives already banned in the European Union—titanium dioxide, brominated vegetable oil, potassium bromates, propyl paraben, and synthetic Red 3—to align U.S. food safety standards with international science.

Ban PBM Spread Pricing and Require Rebate Transparency
Eliminate hidden fees from pharmacy benefit managers and require full price pass-through to patients and insurers.

Dental and Vision Coverage Add-On
Phase in basic dental and vision coverage under Medicare.

Physician Supply Surge

Triple J-1 waiver slots, add 10,000 new Medicare funded residencies, and grant provisional U.S. licenses to doctors from peer OECD countries after a one-year supervised practicum.

Med-School Seat Expansion

federal grants boost class sizes 20 percent at schools partnering with safety-net hospitals, offsetting tuition $25 k per added seat for students from underserved counties.

Advanced Nurse Authority

Offer a 5 percent Medicare/Medicaid bonus to states that let nurse practitioners and physician assistants practice independently, backed by a national malpractice pool and standardized guidelines.

Reciprocal Drug Approval
Automatically approve medicines in the U.S. within 90 days if already approved by trusted foreign regulators (EU, Japan, UK) unless clear safety risks are identified.

Site Neutral Medicare Payments
Standardize Medicare payments across hospital owned outpatient facilities and independent physician offices to prevent overcharging for identical procedures.

Default Open Enrollment for ACA Plans

Auto enroll uninsured adults into zero premium benchmark plans with opt out.

Fund Ethical Challenge Trials
Allow the FDA to oversee safe, paid human challenge trials to speed up development of vaccines and antimicrobial drugs.

Build a National Health Data Commons
Open anonymized health and genomic data to all U.S. researchers and fund access with public cloud credits to accelerate cures and breakthroughs.

Medical Malpractice Safe Harbors
Limit liability when providers follow evidence-based clinical guidelines, while preserving full accountability for negligence, misconduct, or fraud.

Specialized Health Courts
Create expert medical courts to resolve malpractice claims faster, reduce legal overhead, and deliver quicker compensation without shielding bad care.

Expand Eligibility for Free School Meals
Make school lunch free for all students to end food insecurity during the school day.

Reform Health Tech Regulation to Enable Startup Competition
Create a fast-track regulatory framework for digital health tools and AI-powered care delivery, with clear APIs for interoperability.

Fast-Track Clinical Trials for Life-Saving Therapies
Exempt Phase 1 trials from full GMP requirements, allow partial holds instead of full freezes, and normalize adaptive, remote, and digital trial designs to accelerate breakthrough treatments safely.

Progressive Drug Approvals with Real-Time Monitoring
Approve promising therapies once safety is shown, pair with continuous post-market data collection, and right-size rare-disease trials so cures aren’t mathematically impossible.

AI-Driven FDA Review
Require machine-readable clinical data, real-time submission, and AI triage to cut drug review timelines from years to weeks while maintaining rigorous oversight.

Onshore Critical Drug Manufacturing
Mandate domestic or allied-nation production capacity for essential medicines to reduce dependency on China and ensure resilience against supply chain shocks.

Equal Enforcement for Foreign Drug Plants
Apply the same surprise-inspection regime to foreign manufacturers that U.S. facilities face, ending lower regulatory standards abroad.

Rapid-Response Drug Manufacturing Capacity
Fund competitive programs to build flexible U.S. drug factories capable of scaling production quickly during crises, modeled after Operation Warp Speed.

Make Clinical Trials Cheaper and Faster

Cut red tape that makes trials take years and cost hundreds of millions. Replace outdated paperwork with simple consent, expand risk-based monitoring, and allow digital and decentralized trial designs so promising treatments reach patients sooner.

Expand Trial Access for Working Families

Guarantee Medicaid and insurer coverage of routine trial costs, allow fair participant compensation, and modernize ClinicalTrials.gov so patients can actually find trials. Bring research into community hospitals, not just elite academic centers.

Build Shared Trial Platforms for Rare Diseases

Stand up national platform trials that let companies share control groups and test multiple therapies at once, ending the math problem that makes rare-disease cures almost impossible and slashing development time and cost.